Week of January 24, 2023 | Vol. 12, Issue 3

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

A trio of biotechs consolidate as M&A fails to materialize at JPM

Fierce Biotech - Jan 17, 2023

Sanofi inks 5-year deal with Thread to adopt more technology into trials

Fierce Biotech - Jan 17, 2023

BioCentriq Completes Tech Transfer From Avenge Bio

Contract Pharma - Jan 18, 2023

Upperton Pharma Solutions Breaks Ground on New Facility

Contract Pharma - Jan 18, 2023

Sun Pharma to Acquire Concert Pharmaceuticals for $576M

Contract Pharma - Jan 19, 2023

PsychoGenics on board for Iama's preclinical Dravet syndrome therapy study

Fierce Biotech - Jan 19, 2023

Pfizer to Acquire Manufacturing Site in North Carolina from Abzena

Contract Pharma - Jan 20, 2023

Charles River & Rznomics Partner to Initiate Clinical Development of RZ-001

Contract Pharma - Jan 20, 2023

TANNER NEWS

'A Rare Affair'

Congrats to all those who made this event a great success! Tanner was honored to serve as a gold sponsor in support of the Osteogenesis Imperfecta Foundation alongside other rare disease advocates. Learn more..

Increasing the Efficiency of Clinical Trials

The global generic drugs market is projected to be worth $384.4bn within the next five years. Learn more what it means for both patients and drug manufacturers here.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.